More than 10,000 genetic diseases have been identified, ranging from conditions caused by a single misprint in one gene to complex disorders driven by dozens of genetic variants combined with lifestyle factors. Some are extremely rare, affecting only a handful of families worldwide, while others touch millions of people. Genetic diseases generally fall into three categories: single-gene disorders, chromosomal abnormalities, and multifactorial conditions.
Single-Gene Disorders
Single-gene (or monogenic) disorders are caused by a mutation in one specific gene. Because the cause is so precise, these conditions often follow predictable inheritance patterns, meaning you can trace them through a family tree. Some of the most well-known genetic diseases fall into this group.
Cystic fibrosis results from mutations in a gene that controls how salt moves in and out of cells. When that protein is faulty or nearly absent, thick, sticky mucus builds up in the lungs, pancreas, and other organs. Over 2,000 different mutations in this single gene can cause the disease, which is why severity varies so much from person to person. It is most common in people of Northern European descent.
Sickle cell disease is caused by a mutation that changes the shape of red blood cells from round discs into rigid crescents. These misshapen cells get stuck in small blood vessels, causing episodes of severe pain, organ damage, and anemia. It affects millions of people globally, particularly those with ancestry from sub-Saharan Africa, the Middle East, and South Asia.
Huntington’s disease involves a section of DNA that repeats too many times within a single gene. Most people have 10 to 35 copies of this repeating segment. People with 40 or more copies almost always develop the disorder, which progressively damages nerve cells in the brain. Symptoms typically appear in a person’s thirties or forties, starting with subtle mood changes and coordination problems before advancing to severe movement and cognitive difficulties. A less common juvenile form can begin in childhood.
Hemophilia is an X-linked disorder, meaning the mutated gene sits on the X chromosome. Because males have only one X chromosome, they are affected far more often. Hemophilia A, the more common form, occurs in roughly 1 in 4,000 to 5,000 males worldwide. Hemophilia B is rarer, affecting about 1 in 20,000 males. Both types impair the blood’s ability to clot, leading to prolonged bleeding from injuries and, in severe cases, spontaneous internal bleeding.
Chromosomal Abnormalities
Instead of a single gene going wrong, chromosomal disorders involve missing, extra, or rearranged chunks of entire chromosomes. Since each chromosome holds hundreds or thousands of genes, these conditions tend to affect multiple body systems at once.
Down syndrome (trisomy 21) is the most familiar example. It occurs when a person has three copies of chromosome 21 instead of the usual two. About 5,700 babies are born with Down syndrome in the United States each year, roughly 1 in every 640 births. The extra chromosome affects development in ways that vary widely: some individuals live largely independently, while others need significant support. Common features include intellectual disability, characteristic facial features, and a higher risk of heart defects.
Other chromosomal conditions include Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13), both of which involve extra copies of different chromosomes and cause severe developmental problems. Sex chromosome abnormalities, such as Turner syndrome (a missing X chromosome in females) and Klinefelter syndrome (an extra X chromosome in males), tend to be less severe but can affect growth, fertility, and hormone levels.
Multifactorial (Complex) Genetic Conditions
Most common diseases with a genetic component don’t follow a simple one-gene, one-disease pattern. Instead, they arise from a combination of many small genetic variants scattered across the genome, interacting with environmental factors like diet, stress, smoking, and physical activity.
Coronary artery disease is a clear example. Researchers have identified about 60 genomic variants that appear more frequently in people who develop the condition, and these variants are spread across many different chromosomes rather than clustered in one spot. No single variant causes heart disease on its own, but carrying many of them raises your baseline risk. Type 2 diabetes, most cancers, asthma, and many psychiatric conditions work the same way.
Scientists now calculate “polygenic risk scores” that add up the effect of hundreds or thousands of small genetic variants to estimate a person’s likelihood of developing a complex disease. These scores are becoming more common in research, though they’re still limited in clinical use because environment and behavior play such a large role in whether someone actually gets sick.
How Genetic Diseases Are Inherited
The way a genetic condition passes through families depends on where the mutation sits and how many copies are needed to cause disease. In autosomal dominant conditions like Huntington’s disease, inheriting just one copy of the mutated gene from either parent is enough. Each child of an affected parent has a 50% chance of inheriting it.
In autosomal recessive conditions like cystic fibrosis and sickle cell disease, you need two copies of the mutation, one from each parent. People carrying a single copy are called carriers and typically have no symptoms. When two carriers have a child, there’s a 25% chance the child will have the disease.
X-linked recessive conditions like hemophilia primarily affect males because they have only one X chromosome. A mother who carries the mutation on one of her X chromosomes has a 50% chance of passing it to each son, who would then be affected. Daughters who inherit the mutation usually become carriers without symptoms because their second X chromosome compensates.
How Genetic Diseases Are Detected
Genetic testing has become far more accessible. Whole exome sequencing reads the protein-coding portions of your DNA, which is where most known disease-causing mutations sit. It’s an efficient way to search for a diagnosis when symptoms suggest a genetic cause. Whole genome sequencing goes further, reading the entire DNA sequence including regions between genes. This catches mutations that exome sequencing misses, since researchers have found that DNA variations outside protein-coding regions can also disrupt gene activity.
For pregnancies, noninvasive prenatal testing (NIPT) uses a simple blood draw from the mother to screen for chromosomal conditions like Down syndrome, Edwards syndrome, and Patau syndrome. It can also check for sex chromosome abnormalities and the fetus’s blood type. The false-positive rate for detecting trisomy 21 and trisomy 18 is low, about 0.2%, but a positive screening result still needs confirmation through more definitive testing like amniocentesis.
Gene Therapy Is Changing the Outlook
For decades, managing genetic diseases meant treating symptoms. That’s changing. In 2024, regulators approved several gene therapies that target the root genetic cause of disease. One therapy treats moderate to severe hemophilia B by delivering a working copy of the clotting factor gene directly into cells. Another uses gene editing technology to modify a patient’s own cells as a treatment for sickle cell disease and beta thalassemia, making it the first approved gene-editing therapy for these blood disorders.
Even ultra-rare conditions are getting attention. A gene therapy was approved in late 2024 for a rare enzyme deficiency that affects brain development in infants, delivering the missing gene directly to the brain. These treatments are still limited to specific diseases and often come with high costs and restricted availability, but they represent a fundamental shift from managing symptoms to correcting the underlying genetic problem.